Work for IBIO, Inc.?

Claim Your Profile

IBIO, Inc. Logo Image

IBIO, Inc.

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2016 Annual Report, Interactive Annual Report and Form 10K

IBIO, Inc.

IBIO, Inc. has reached its limit for free report views.

IBIO, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

Archived Annual Reports

About IBIO, Inc.

11-50 Employees
Based in New York, New York

iBio is developing proprietary products for the treatment of a range of fibrotic diseases including idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. IBIO-CFB03, produced using the Company's proprietary gene expression technology, is the first product candidate from this program being advanced for IND development. The Company also offers proprietary products and product licenses to others based on its proprietary technologies, providing collaborators full support for turn-key implementation of its technology for protein therapeutics and vaccines.

Ticker:
IBIO
Exchange:
NYSE (See More NYSE Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol